Allergy Diagnostics Market Analysis and Forecast to 2031: By Product & Services (Consumables, Instruments, Services), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Others), Test Type (In Vivo Tests, In Vitro Tests), End Users (Diagnostic La

Allergy Diagnostics Market Analysis and Forecast to 2031: By Product & Services (Consumables, Instruments, Services), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Others), Test Type (In Vivo Tests, In Vitro Tests), End Users (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes), and Region

The allergy diagnostics market was valued at USD 5 billion in 2021 and it is anticipated to grow further up to USD 14.1 billion by 2031 at a CAGR of 10.9% during the forecast period (2022-2031).


An allergy is a hypersensitivity condition of the immune system. Allergic reactions occur when a person’s immune system reacts to harmless substances which are named allergens in the environment. Major allergens that affect the immune system are dust mites’ excretion, pollen, and pet dander. There are different kinds of allergies such as food allergy, skin allergy, dust allergy, allergy to insect stings, drug allergy, and mold allergy. Food allergy is generally caused by the consumption of certain proteins found in food and may activate symptoms such as hives and digestive problems.

Scope of the ReportMarket DriversIncreasing environmental pollution levels

Exposure to indoor and outdoor air pollutants, allergens, and occupational exposure are the major risk factors that cause chronic respiratory diseases. The prevalence of allergic disorders among the urban population is higher than those living in rural areas owing to the high exposure to environmental pollutants in cities. A new WHO air quality model confirms that 92% of the world’s population lives in places where air quality levels exceed WHO limits. Some 3 million deaths per year are linked to exposure to outdoor air pollution. Indoor air pollution can be just as deadly. In 2012, an estimated 6.5 million deaths (11.6% of global deaths) were associated with indoor and outdoor air pollution together.

Use of mHealth in allergy diagnosis

Recent developments in integrated biosensors, wireless communication, and power harvesting techniques generate a new class of point-of-care devices. Conversely, AR is a very common disease. Any diagnostic device connected to a smartphone (e.g., peak nasal inspiratory flow meters or intranasal biosensors) would need to be inexpensive to be affordable.


The monitoring of the control of allergic multimorbidity (rhinitis, conjunctivitis, and asthma) has been approached by various apps. An allergy monitor, for instance, assists in monitoring the symptoms and medication intake, which is then matched to local pollen concentrations.

Market RestraintsPremium costs associated with allergy diagnostic instruments

Several allergy diagnostics instruments, like luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers, are continually updated by market players. As these instruments are equipped with advanced features coupled with functionalities, they are priced at a premium (the price of each instrument varies based on its accuracy, flexibility, and TAT). Moreover, maintenance and insurance, laboratory supervision, and overheads (including utilities, space, and administration) are additional expenses essential to operating this equipment.

Impact of COVID-19 on Allergy Diagnostics Market

The market for allergy diagnostics witnessed a slight decline owing to the outbreak of COVID across the globe. Diagnostic procedures were postponed in most allergic diseases, considering the affected patients are well instructed regarding avoidance of potential environmental activators and treatment of acute events, also based on written action plans. Still, the diagnostic procedures were resumed as soon as the pandemic got under control.

Market Segmental Analysis

The global allergy diagnostics market is segmented into products & services, allergen, test type, and end user.

Global Allergy Diagnostics Market by Product & Services

The various products & services considered in the global allergy diagnostics market are consumables, instruments, and services. The instruments segment is also sub-segmented into immunoassay analyzers, ELISA analyzers, luminometers, and other instruments.


The consumable segment is likely to dominate the market. The key factors such as rising cases of allergies coupled with the need for rapid tests to diagnose allergic conditions are likely to boost the growth of the segment during the forecast period.

Global Allergy Diagnostics Market by Allergen

The various allergens such as inhaled allergens, food allergens, drug allergens, and others are comprised in the global allergy diagnostics market.


The inhaled allergens segment is estimated to dominate the market. The key factors such as increasing environmental pollution combined with rising pollen coupled with other factors like fungus, mold, and dust are propelling the growth of the segment in the market.

Global Allergy Diagnostics Market by Test Type

Test types, such as in vivo tests and in vitro tests are comprised in the global allergy diagnostics market. The in vitro tests segment is also sub-segmented into skin prick tests, patch tests, and other in vivo tests.


In vivo tests is likely to dominate the global allergy diagnostics market. The key factors such as increasing adoption of various in vivo tests, such as skin prick test is boosting the growth of the segment. These tests are dependable, safe, convenient, and cost-effective, as compared to in vitro tests.

Global Allergy Diagnostics Market by End Users

The end-users such as diagnostic laboratories, hospital-based laboratories, and academic research institutes are comprised in the global allergy diagnostics market.


The diagnostic laboratories segment is likely to dominate the market. The large share of the segment can be primarily attributed to the preference for proper diagnosis from a specialist coupled with rising awareness regarding the management of allergic diseases, and the availability of funds for the operation of independent diagnostic laboratories. These factors are likely to propel the growth of the segment during the forecast period.

Geographical Analysis of Global Allergy Diagnostics Market

The global allergy diagnostics market is studied for various key countries of the regions such as North America, Europe, Asia Pacific, and the Rest of the World.

 North America is likely to dominate the market during the forecast period. The key factors such as growing cases of allergies coupled with favorable reimbursement scenarios for allergy diagnosis, and the availability of supportive initiatives by associations are boosting the growth of the region.Market Players of Global Allergy Diagnostics MarketKey Developments in Global Allergy Diagnostics Market

• July 2021: Hitachi Chemical Diagnostics, Inc. is renamed to Minaris Medical America Inc., and its group company Hitachi Chemical Diagnostics Systems Co., Ltd. Is renamed to Minaris Medical Co., Ltd.
• May 2021: Perkin Elmer Inc., entered into an agreement with Immunodiagnostic Systems Holdings PLC to acquire the later. The acquisition will enable PerkinElmer Inc. to strengthen its position in the ImmunoDiagnostics market.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.